Safe use of MRI in people with cardiac implantable electronic devices

Heart

Volumn 101, Issue 24, 2015, Pages 1950-1953

  Lowe, Martin D ^a   Plummer, Christopher J ^b   Manisty, Charlotte H ^c   Linker, Nicholas J ^d  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CARDIOVASCULAR THERAPEUTIC DEVICE; CLINICAL EFFECTIVENESS; DEVICE SAFETY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT INDICATION; ADVERSE EFFECTS; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVERSION; DEVICES; HEART DISEASES; HEART PACING; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROSTHESIS; PROSTHESIS FAILURE; REPRODUCIBILITY; STANDARDS;

CARDIAC PACING, ARTIFICIAL; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84951863779     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308495     Document Type: Review

References (11)

1. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326-8.
2. Shellock FG, Crues JV. MR safety and the American College of Radiology white paper. Am J Roentgenol 2002;178:1349-52.
3. Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878-91.
4. Roguin A, Schwitter J, Vahlhaus C, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-46.
5. Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011;8:65-73.
6. Rod Gimbel J, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm 2013;10:685-91.
7. Pohost GM, Blackwell GG, Shellock FG. Safety of patients with medical devices during application of magnetic resonance methods. Ann N Y Acad Sci 1992;649:302-12.
8. Gimbel JR, Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol 2004;43:1325-7.
9. Russo RJ. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry. Am Heart J 2013;165:266-72.
10. Russo RJ. Determining the risks of magnetic resonance imaging at 1.5 Tesla for patients with non-MRI conditional pacemakers and implantable cardioverter defibrillators: final results of the MagnaSafe registry. Presented at American Heart Association Scientific Sessions, Chicago, 2014.
11. Keller J, Neuzil P, Vymazal J, et al. Magnetic Resonance Imaging in patients with a subcutaneous implantable cardioverter-defibrillator. Europace 2015;17:761-6.